biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > S&P Biotech ETF now down 38% this year alone

<< Previous

Bullboard Posts

Next >>

Comment by fatboy92on May 08, 2022 10:44am

148 Views

Post# 34665335

RE:RE:RE:RE:RE:S&P Biotech ETF now down 38% this year alone

There goes beenthere again, after downing half dozen Newfoundland screech your back to posting advice that you should be take heed of...if you took your own advice from the last two post, we possible wouldn't have to see any of your nonsense for at least a couple of years, if not ever. What a wonderful thought that is.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario